A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. - Gillies,M.C.; Simpson,J.M.; Luo,W.; Penfold,P.; Hunyor,A.B.; Chua,W.; Mitchell,P.; Billson,F. (Arch Ophthalmol, 2003)